Greece Omega 3 Market Size & Outlook, 2026-2033
Global Market
Related Markets
Greece omega 3 market highlights
- The Greece omega 3 market generated a revenue of USD 14.2 million in 2025 and is expected to reach USD 23.2 million by 2033.
- The Greece market is expected to grow at a CAGR of 6.28% from 2026 to 2033.
- In terms of segment, docosahexaenoic acid (dha) was the largest revenue generating type in 2025.
- DPA is the most lucrative type segment registering the fastest growth during the forecast period.
Omega 3 market data book summary
| Market revenue in 2025 | USD 14.2 million |
| Market revenue in 2033 | USD 23.2 million |
| Growth rate | 6.28% (CAGR from 2026 to 2033) |
| Largest segment | Docosahexaenoic acid (dha) |
| Fastest growing segment | DPA |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA), Alpha-linolenic acid (ALA), DPA, Others Type |
| Key market players worldwide | Orkla ASA, Basf SE, Omega Laboratories, Lonza Group Ltd, Croda International PLC, Austevoll Seafood ASA, Koninklijke DSM NV |
Other key industry trends
- In terms of revenue, Greece accounted for 0.5% of the global omega 3 market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany omega 3 market is projected to lead the regional market in terms of revenue in 2033.
- Netherlands is the fastest growing regional market in Europe and is projected to reach USD 83.1 million by 2033.
Greece has one of the most robust pharmaceutical industries in the world. Additionally, the Ministry of Finance of the Government of Greece has approved a new program clearing the path for investment worth more than a billion USD. This investment is aimed to fund research and development programs related to the pharmaceuticals industry in Greece.
The approval effectively highlights a total of 53 investments in pharmaceutical related research and development projects in the country. Such massive investments in the pharmaceuticals industry are poised to increase the consumption of omega3 in Greece in the coming years.
No credit card required*
Publish Date: Jul 06, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Omega 3 Market Scope
Omega 3 Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Koninklijke DSM NV | View profile | 20,682 | Het Overloon 1, P.O. Box 6500, Heerlen, LI, Netherlands, 6411 TE | www.dsm.com |
| Basf SE | View profile | 111,855 | Carl-Bosch-Strasse 38, Ludwigshafen am Rhein, Germany, 67056 | www.basf.com |
| Lonza Group Ltd | View profile | 18,000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | www.lonza.com |
| Croda International PLC | View profile | 5,852 | Cowick Hall, Snaith, Goole, East Yorkshire, United Kingdom, DN14 9AA | www.croda.com |
| Omega Laboratories | View profile | 101-250 | Mogadore, Ohio, United States, North America | www.omegalaboratories.com/ |
| Orkla ASA | View profile | 19,671 | Drammensveien 149, Oslo, Norway, NO-0277 | www.orkla.no |
| Austevoll Seafood ASA | View profile | 7,022 | Alfabygget, Storebo, Norway, 5392 | www.auss.no |
Greece Omega 3 Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Omega 3 Market Outlook will help companies and investors design strategic landscapes.
Docosahexaenoic Acid (Dha) was the largest segment with a revenue share of 57.75% in 2025.
Horizon Databook has segmented the Greece omega 3 market based on docosahexaenoic acid (dha), eicosapentaenoic acid (epa), alpha-linolenic acid (ala), dpa, others type covering the revenue growth of each sub-segment from 2021 to 2033.
Greece has one of the most robust pharmaceutical industries in the world. Additionally, the Ministry of Finance of the Government of Greece has approved a new program clearing the path for investment worth more than a billion USD. This investment is aimed to fund research and development programs related to the pharmaceuticals industry in Greece.
The approval effectively highlights a total of 53 investments in pharmaceutical related research and development projects in the country. Such massive investments in the pharmaceuticals industry are poised to increase the consumption of omega3 in Greece in the coming years.
- Greece Omega 3 Market Type Outlook (Revenue, USD Million , 2021-2033)
- Docosahexaenoic acid (DHA)
- Eicosapentaenoic acid (EPA)
- Alpha-linolenic acid (ALA)
- DPA
- Others Type
- Greece Omega 3 Market Application Outlook (Revenue, USD Million , 2021-2033)
- Others Application
- Pharmaceuticals
- Infant Formula
- Supplements & Functional Foods
- Animal Feed & Pet Food
- Greece Omega 3 Market Source Outlook (Revenue, USD Million , 2021-2033)
- Marine Source
- Plant Source
Reasons to subscribe to Omega 3 Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Omega 3 Market Outlook databook
- Our clientele includes a mix of Omega 3 Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Greece Omega 3 Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Greece Omega 3 Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Greece Omega 3 Market, 2021-2033 (US$M)
Greece omega 3 market statistics, by type, 2021-2033 (US$M)
